Repligen | Aktywa





Aktywa Zmiana Data
Agilent USD 12.73B 501M 2025-09
Align Technology USD 6.23B 141K 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Bruker USD 6.43B 95.1M 2025-09
Charles River Laboratories USD 7.51B 46.73M 2025-09
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.65B 416M 2025-09
Exact Sciences USD 5.9B 102.64M 2025-09
General Electric Aerospace USD 130.17B 1.93B 2025-12
Henry Schein USD 11.1B 191M 2025-09
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Repligen USD 2.92B 22.08M 2025-09
Revvity USD 12.14B 223.84M 2025-09
Standard Biotools USD 539.64M 17.32M 2025-09
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Waters USD 4.86B 144.49M 2025-09
West Pharmaceutical Services USD 4.11B 153M 2025-09


Repligen Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.